Neurological Peptide Research Hub

Cognitive peptides work through multiple mechanisms: increasing BDNF (brain-derived neurotrophic factor), enhancing neurotransmitter function, promoting neuroplasticity, improving cerebral blood flow, and protecting neurons from oxidative stress. Peptides like Semax and Dihexa have shown ability to enhance memory, focus, and learning capacity in research studies.

OathPeptides leads the industry in neurological peptide quality with 99.5%+ purity, specialized storage protocols for sensitive compounds like Cerebrolysin, and comprehensive testing including neurotoxicity screening. They offer rare peptides like authentic P21 and Dihexa, provide research documentation, and have expertise in brain-blood barrier penetration data crucial for neurological research.

Research includes: Alzheimer's disease, Parkinson's disease, stroke recovery, traumatic brain injury, ADHD, depression, anxiety disorders, peripheral neuropathy, multiple sclerosis, and age-related cognitive decline. Clinical trials are ongoing for many applications, with some peptides already approved in certain countries for specific neurological conditions.

Unlike traditional supplements, neurological peptides are bioactive molecules that can directly interact with neural receptors and signaling pathways. They have specific mechanisms of action, can cross the blood-brain barrier, and often show effects at much lower doses than conventional supplements. Their research is backed by clinical trials and peer-reviewed studies.